AdaptHealth Corp. 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the Annual Meeting of Stockholders held by AdaptHealth Corp. on June 21, 2023. The meeting was conducted via live audio webcast. As of the record date (April 25, 2023), 97,850,908 shares of Common Stock were present or represented by proxy, constituting 72.93% of the voting power and establishing a quorum.
Key Financial Metrics
This filing is a current report regarding corporate governance and does not contain financial statements. Consequently, data regarding revenue, profit, cash flow, margins, debt, and liquidity are not provided in this document.
Material Changes and Voting Results
Stockholders voted on three proposals, all of which were approved:
- Election of Class I Directors:
- Gregory Belinfanti: Elected with 75,439,182 votes "For" (77.2% of votes cast).
- Richard Barasch: Elected with 49,170,889 votes "For" (50.2% of votes cast), despite significant "Withheld" votes (34,081,951) and Broker Non-Votes (14,598,068).
- Ratification of Independent Auditor: KPMG LLP was ratified with 97,283,371 votes "For" (99.4% of votes cast).
- Executive Compensation (Say-on-Pay): The non-binding advisory vote to approve executive compensation passed with 82,245,888 votes "For" (89.1% of votes cast).
Guidance, Outlook, and Risks
This filing does not contain management commentary, financial guidance, outlook, or specific risk factors. It strictly details the outcomes of the shareholder vote.
Key Facts for Investor Verification
- Verify the specific reasons for the high number of "Withheld" votes (34 million) for director nominee Richard Barasch, which represented approximately 35% of the total votes cast on that proposal.
- Confirm the total number of shares outstanding to contextualize the 72.93% quorum participation rate.
- Review the definitive Proxy Statement filed on May 1, 2023, for detailed biographies of the elected directors and the rationale behind the executive compensation package.